MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
 

Announcements, events, and other news coverage

 
 
TRIMTECH Therapeutics named as one of Fierce Biotech’s ‘Fierce 15’ for 2025
Guest UserSeptember 29, 2025
Blacksmith Medicines Granted U.S. Patent Covering Antibacterial Compounds Targeting LpxC
Guest UserJuly 3, 2025
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins
Guest UserJuly 17, 2024
PharmEnable Therapeutics and Sosei Heptares Expand Drug Discovery Collaboration
Guest UserOctober 11, 2023
FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES ( Editforce )
Guest UserMarch 22, 2023
EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT
Guest UserJune 27, 2022
Sonde Health Partners with GN Group to Research and Develop New Vocal Biomarker Technology to Detect Mild Cognitive Impairment
Guest UserJanuary 18, 2022
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
Guest UserJanuary 5, 2022
Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine through its Pipeline of RNA Editing Programs
Guest UserJanuary 5, 2022
LiberoThera Secures 300 Million JPY Financing Agreement with Taiho Ventures
Guest UserAugust 5, 2021
EditForce completed fund raising by third-party allotment and AMED adopts our program
Guest UserJune 30, 2021
LiberoThera Closes 535 Million JPY Financing to Develop GPCR-targeting Therapeutics
Guest UserMay 14, 2021
BIOGEN AND CAPSIGEN ANNOUNCE COLLABORATION TO DISCOVER AND DEVELOP NOVEL AAV CAPSIDS FOR TARGETED CNS AND NEUROMUSCULAR DISORDERS
Guest UserMay 10, 2021
Blacksmith Medicines launches with seed funding and a research collaboration with Lilly
Guest UserJanuary 8, 2021
Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics
Guest UserJanuary 6, 2021
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
Guest UserNovember 20, 2020
Korro Bio Closes $91.5 Million Series A Financing to Advance the Next Frontier in RNA Therapeutics
Guest UserSeptember 10, 2020
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
Guest UserJuly 29, 2020
Merck KGaA, Darmstadt, Germany Takes an Early Option in Immuno-Oncology Collaboration
Guest UserJuly 16, 2020
Sonde Health Launches New Voice-Enabled Health Screening Tool to Help Employers Return to Work During the Global Pandemic
Guest UserJuly 8, 2020
Older

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact